Stock Price
16.48
Daily Change
-0.78 -4.52%
Monthly
17.63%
Yearly
86.43%
Q2 Forecast
16.15

Viatris reported $0.59 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.59 0.52 0.50 May/07
FY2025Q4 Dec/2025 0.57 0.53 0.54 Feb/26
FY2025Q3 Sep/2025 0.67 0.62 0.75 Nov/06
FY2025Q2 Jun/2025 0.62 0.55 0.69 Aug/07
FY2025Q1 Mar/2025 0.50 0.53 0.67 May/08




Eps Change Date
Celltrion KRW 1.58K 709.78 Mar/2026
Cspc Pharmaceutical CNY 0 0.08 Dec/2025
Deva Holding AS TRY 2.92 1.6 Sep/2023
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Divis Laboratories Ltd INR 21.98 3.99 Dec/2025
Kangmei Pharma CNY 0 0 Sep/2025
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR -0.06 0.1 Dec/2023
Medical Developments International AUD 0 0 Dec/2025
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organigram Holdings CAD -0.16 0.02 Dec/2025
Ovoca Bio EUR -0.06 0.01 Jun/2025
Pharma Mar EUR 0.09 3.25 Mar/2026
Qiagen NV USD 0.46 0.06 Mar/2026
Sartorius EUR 1.2 0.06 Mar/2026
Sino Biopharmaceutical CNY -0.06 0.22 Dec/2025
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.59 0.02 Mar/2026
Zealand Pharma A/S -8.34 2.6 Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 1.24 0.51 Mar/2026